Brief: Aker BioMarine Q3 Adjusted EBITDA USD 12.2 Million
31/10/2025 06:00
Oct 31 (Reuters) - Aker BioMarine Q3 revenue USD 56.8 million.
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million